Hot topics
Severe asthma phenotyping
Translational
Using clinically-relevant biomarkers
Aims : To describe the state of the art regarding the four main severe asthma phenotypes, provide insights into the role of clinically-relevant biomarkers that relate to different phenotypes; and discuss the usefulness of biologics as add-on therapy in selected severe asthma phenotypes.
Chairs
P. Sterk
Koudekerk aan den Rijn
(Netherlands)
08:30
Early-onset allergic severe asthma
R. Djukanovic(Southampton (Hampshire), United Kingdom)
COI
1
4722
09:00
Late-onset persistent eosinophilic severe asthma
I. Pavord(Oxford (Oxfordshire), United Kingdom)
COI
2
4723
09:30
Obesity-related severe asthma
S. Shore(Boston, United States)
COI
3
4724
10:00
Neutrophilic severe asthma
F. Ricciardolo(Torino, Italy)
COI
4
4725
. . .